COVID-19 Impact on Global Anti-CD20 Monoclonal Antibodies Market Insights, Forecast to 2026

Publisher Name :
Date: 14-May-2020
No. of pages: 113
Inquire Before Buying

Anti-CD20 Monoclonal Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-CD20 Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Anti-CD20 Monoclonal Antibodies market is segmented into

- First Generation Anti-CD20 Monoclonal Antibody

- Second Generation Anti-CD20 Monoclonal Antibody

- Third Generation Anti-CD20 Monoclonal Antibody

Segment by Application, the Anti-CD20 Monoclonal Antibodies market is segmented into

- Oncology

- Neurology

- Immunology

Regional and Country-level AnalysisThe Anti-CD20 Monoclonal Antibodies market is analysed and market size information is provided by regions (countries).

The key regions covered in the Anti-CD20 Monoclonal Antibodies market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Anti-CD20 Monoclonal Antibodies Market Share Analysis

Anti-CD20 Monoclonal Antibodies market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-CD20 Monoclonal Antibodies business, the date to enter into the Anti-CD20 Monoclonal Antibodies market, Anti-CD20 Monoclonal Antibodies product introduction, recent developments, etc.

The major vendors covered:

- Genmab

- Amgen

- Celltrion

- Roche

- Novartis AG

- Pfizer

- Biogen

- Genentech

- Immunomedics

- Spectrum Pharmaceuticals

- Bio-Rad Laboratories

- LFB Biotechnologie

COVID-19 Impact on Global Anti-CD20 Monoclonal Antibodies Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Anti-CD20 Monoclonal Antibodies Product Introduction
1.2 Market Segments
1.3 Key Anti-CD20 Monoclonal Antibodies Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Type
1.4.2 First Generation Anti-CD20 Monoclonal Antibody
1.4.3 Second Generation Anti-CD20 Monoclonal Antibody
1.4.4 Third Generation Anti-CD20 Monoclonal Antibody
1.5 Market by Application
1.5.1 Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Neurology
1.5.4 Immunology
1.6 Coronavirus Disease 2019 (Covid-19): Anti-CD20 Monoclonal Antibodies Industry Impact
1.6.1 How the Covid-19 is Affecting the Anti-CD20 Monoclonal Antibodies Industry
1.6.1.1 Anti-CD20 Monoclonal Antibodies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Anti-CD20 Monoclonal Antibodies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Anti-CD20 Monoclonal Antibodies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Anti-CD20 Monoclonal Antibodies Market Size Estimates and Forecasts
2.1.1 Global Anti-CD20 Monoclonal Antibodies Revenue 2015-2026
2.1.2 Global Anti-CD20 Monoclonal Antibodies Sales 2015-2026
2.2 Anti-CD20 Monoclonal Antibodies Market Size by Region: 2020 Versus 2026
2.2.1 Global Anti-CD20 Monoclonal Antibodies Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-CD20 Monoclonal Antibodies Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-CD20 Monoclonal Antibodies Competitor Landscape by Players
3.1 Anti-CD20 Monoclonal Antibodies Sales by Manufacturers
3.1.1 Anti-CD20 Monoclonal Antibodies Sales by Manufacturers (2015-2020)
3.1.2 Anti-CD20 Monoclonal Antibodies Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-CD20 Monoclonal Antibodies Revenue by Manufacturers
3.2.1 Anti-CD20 Monoclonal Antibodies Revenue by Manufacturers (2015-2020)
3.2.2 Anti-CD20 Monoclonal Antibodies Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-CD20 Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-CD20 Monoclonal Antibodies Revenue in 2019
3.2.5 Global Anti-CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-CD20 Monoclonal Antibodies Price by Manufacturers
3.4 Anti-CD20 Monoclonal Antibodies Manufacturing Base Distribution, Product Types
3.4.1 Anti-CD20 Monoclonal Antibodies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-CD20 Monoclonal Antibodies Product Type
3.4.3 Date of International Manufacturers Enter into Anti-CD20 Monoclonal Antibodies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Anti-CD20 Monoclonal Antibodies Market Size by Type (2015-2020)
4.1.1 Global Anti-CD20 Monoclonal Antibodies Sales by Type (2015-2020)
4.1.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2015-2020)
4.1.3 Anti-CD20 Monoclonal Antibodies Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-CD20 Monoclonal Antibodies Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Type (2021-2026)
4.2.3 Anti-CD20 Monoclonal Antibodies Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-CD20 Monoclonal Antibodies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Anti-CD20 Monoclonal Antibodies Market Size by Application (2015-2020)
5.1.1 Global Anti-CD20 Monoclonal Antibodies Sales by Application (2015-2020)
5.1.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Application (2015-2020)
5.1.3 Anti-CD20 Monoclonal Antibodies Price by Application (2015-2020)
5.2 Anti-CD20 Monoclonal Antibodies Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-CD20 Monoclonal Antibodies Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-CD20 Monoclonal Antibodies by Country
6.1.1 North America Anti-CD20 Monoclonal Antibodies Sales by Country
6.1.2 North America Anti-CD20 Monoclonal Antibodies Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Type
6.3 North America Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-CD20 Monoclonal Antibodies by Country
7.1.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Country
7.1.2 Europe Anti-CD20 Monoclonal Antibodies Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Type
7.3 Europe Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-CD20 Monoclonal Antibodies by Region
8.1.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region
8.1.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Type
8.3 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-CD20 Monoclonal Antibodies by Country
9.1.1 Latin America Anti-CD20 Monoclonal Antibodies Sales by Country
9.1.2 Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Type
9.3 Central & South America Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies by Country
10.1.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country
10.1.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Type
10.3 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Application
11 Company Profiles
11.1 Genmab
11.1.1 Genmab Corporation Information
11.1.2 Genmab Description, Business Overview and Total Revenue
11.1.3 Genmab Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genmab Anti-CD20 Monoclonal Antibodies Products Offered
11.1.5 Genmab Recent Development
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description, Business Overview and Total Revenue
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Anti-CD20 Monoclonal Antibodies Products Offered
11.2.5 Amgen Recent Development
11.3 Celltrion
11.3.1 Celltrion Corporation Information
11.3.2 Celltrion Description, Business Overview and Total Revenue
11.3.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Celltrion Anti-CD20 Monoclonal Antibodies Products Offered
11.3.5 Celltrion Recent Development
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Description, Business Overview and Total Revenue
11.4.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Roche Anti-CD20 Monoclonal Antibodies Products Offered
11.4.5 Roche Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Corporation Information
11.5.2 Novartis AG Description, Business Overview and Total Revenue
11.5.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis AG Anti-CD20 Monoclonal Antibodies Products Offered
11.5.5 Novartis AG Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Anti-CD20 Monoclonal Antibodies Products Offered
11.6.5 Pfizer Recent Development
11.7 Biogen
11.7.1 Biogen Corporation Information
11.7.2 Biogen Description, Business Overview and Total Revenue
11.7.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biogen Anti-CD20 Monoclonal Antibodies Products Offered
11.7.5 Biogen Recent Development
11.8 Genentech
11.8.1 Genentech Corporation Information
11.8.2 Genentech Description, Business Overview and Total Revenue
11.8.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Genentech Anti-CD20 Monoclonal Antibodies Products Offered
11.8.5 Genentech Recent Development
11.9 Immunomedics
11.9.1 Immunomedics Corporation Information
11.9.2 Immunomedics Description, Business Overview and Total Revenue
11.9.3 Immunomedics Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Immunomedics Anti-CD20 Monoclonal Antibodies Products Offered
11.9.5 Immunomedics Recent Development
11.10 Spectrum Pharmaceuticals
11.10.1 Spectrum Pharmaceuticals Corporation Information
11.10.2 Spectrum Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Spectrum Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Products Offered
11.10.5 Spectrum Pharmaceuticals Recent Development
11.1 Genmab
11.1.1 Genmab Corporation Information
11.1.2 Genmab Description, Business Overview and Total Revenue
11.1.3 Genmab Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genmab Anti-CD20 Monoclonal Antibodies Products Offered
11.1.5 Genmab Recent Development
11.12 LFB Biotechnologie
11.12.1 LFB Biotechnologie Corporation Information
11.12.2 LFB Biotechnologie Description, Business Overview and Total Revenue
11.12.3 LFB Biotechnologie Sales, Revenue and Gross Margin (2015-2020)
11.12.4 LFB Biotechnologie Products Offered
11.12.5 LFB Biotechnologie Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-CD20 Monoclonal Antibodies Market Estimates and Projections by Region
12.1.1 Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Regions 2021-2026
12.2 North America Anti-CD20 Monoclonal Antibodies Market Size Forecast (2021-2026)
12.2.1 North America: Anti-CD20 Monoclonal Antibodies Sales Forecast (2021-2026)
12.2.2 North America: Anti-CD20 Monoclonal Antibodies Revenue Forecast (2021-2026)
12.2.3 North America: Anti-CD20 Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-CD20 Monoclonal Antibodies Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-CD20 Monoclonal Antibodies Sales Forecast (2021-2026)
12.3.2 Europe: Anti-CD20 Monoclonal Antibodies Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-CD20 Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-CD20 Monoclonal Antibodies Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-CD20 Monoclonal Antibodies Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-CD20 Monoclonal Antibodies Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-CD20 Monoclonal Antibodies Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-CD20 Monoclonal Antibodies Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-CD20 Monoclonal Antibodies Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-CD20 Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-CD20 Monoclonal Antibodies Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-CD20 Monoclonal Antibodies Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-CD20 Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Anti-CD20 Monoclonal Antibodies Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-CD20 Monoclonal Antibodies Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Anti-CD20 Monoclonal Antibodies Market Segments
Table 2. Ranking of Global Top Anti-CD20 Monoclonal Antibodies Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Type 2020-2026 (KG) & (US$ Million)
Table 4. Major Manufacturers of First Generation Anti-CD20 Monoclonal Antibody
Table 5. Major Manufacturers of Second Generation Anti-CD20 Monoclonal Antibody
Table 6. Major Manufacturers of Third Generation Anti-CD20 Monoclonal Antibody
Table 7. COVID-19 Impact Global Market: (Four Anti-CD20 Monoclonal Antibodies Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Anti-CD20 Monoclonal Antibodies Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Anti-CD20 Monoclonal Antibodies Players to Combat Covid-19 Impact
Table 12. Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Application 2020-2026 (KG)
Table 13. Global Anti-CD20 Monoclonal Antibodies Market Size by Region (KG) & (US$ Million): 2020 VS 2026
Table 14. Global Anti-CD20 Monoclonal Antibodies Sales by Regions 2015-2020 (KG)
Table 15. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Regions (2015-2020)
Table 16. Global Anti-CD20 Monoclonal Antibodies Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Anti-CD20 Monoclonal Antibodies Sales by Manufacturers (2015-2020) (KG)
Table 18. Global Anti-CD20 Monoclonal Antibodies Sales Share by Manufacturers (2015-2020)
Table 19. Global Anti-CD20 Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Anti-CD20 Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-CD20 Monoclonal Antibodies as of 2019)
Table 21. Anti-CD20 Monoclonal Antibodies Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Anti-CD20 Monoclonal Antibodies Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Anti-CD20 Monoclonal Antibodies Price (2015-2020) (USD/KG)
Table 24. Anti-CD20 Monoclonal Antibodies Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Anti-CD20 Monoclonal Antibodies Product Type
Table 26. Date of International Manufacturers Enter into Anti-CD20 Monoclonal Antibodies Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-CD20 Monoclonal Antibodies Sales by Type (2015-2020) (KG)
Table 29. Global Anti-CD20 Monoclonal Antibodies Sales Share by Type (2015-2020)
Table 30. Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Type (2015-2020)
Table 32. Anti-CD20 Monoclonal Antibodies Average Selling Price (ASP) by Type 2015-2020 (USD/KG)
Table 33. Global Anti-CD20 Monoclonal Antibodies Sales by Application (2015-2020) (KG)
Table 34. Global Anti-CD20 Monoclonal Antibodies Sales Share by Application (2015-2020)
Table 35. North America Anti-CD20 Monoclonal Antibodies Sales by Country (2015-2020) (KG)
Table 36. North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 37. North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 39. North America Anti-CD20 Monoclonal Antibodies Sales by Type (2015-2020) (KG)
Table 40. North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 41. North America Anti-CD20 Monoclonal Antibodies Sales by Application (2015-2020) (KG)
Table 42. North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 43. Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2015-2020) (KG)
Table 44. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 45. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 47. Europe Anti-CD20 Monoclonal Antibodies Sales by Type (2015-2020) (KG)
Table 48. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 49. Europe Anti-CD20 Monoclonal Antibodies Sales by Application (2015-2020) (KG)
Table 50. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2015-2020) (KG)
Table 52. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Type (2015-2020) (KG)
Table 56. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Application (2015-2020) (KG)
Table 58. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 59. Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2015-2020) (KG)
Table 60. Latin America Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Anti-CD20 Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 63. Latin America Anti-CD20 Monoclonal Antibodies Sales by Type (2015-2020) (KG)
Table 64. Latin America Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 65. Latin America Anti-CD20 Monoclonal Antibodies Sales by Application (2015-2020) (KG)
Table 66. Latin America Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2015-2020) (KG)
Table 68. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Type (2015-2020) (KG)
Table 72. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Application (2015-2020) (KG)
Table 74. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 75. Genmab Corporation Information
Table 76. Genmab Description and Major Businesses
Table 77. Genmab Anti-CD20 Monoclonal Antibodies Production (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 78. Genmab Product
Table 79. Genmab Recent Development
Table 80. Amgen Corporation Information
Table 81. Amgen Description and Major Businesses
Table 82. Amgen Anti-CD20 Monoclonal Antibodies Production (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 83. Amgen Product
Table 84. Amgen Recent Development
Table 85. Celltrion Corporation Information
Table 86. Celltrion Description and Major Businesses
Table 87. Celltrion Anti-CD20 Monoclonal Antibodies Production (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 88. Celltrion Product
Table 89. Celltrion Recent Development
Table 90. Roche Corporation Information
Table 91. Roche Description and Major Businesses
Table 92. Roche Anti-CD20 Monoclonal Antibodies Production (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 93. Roche Product
Table 94. Roche Recent Development
Table 95. Novartis AG Corporation Information
Table 96. Novartis AG Description and Major Businesses
Table 97. Novartis AG Anti-CD20 Monoclonal Antibodies Production (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 98. Novartis AG Product
Table 99. Novartis AG Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Major Businesses
Table 102. Pfizer Anti-CD20 Monoclonal Antibodies Production (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 103. Pfizer Product
Table 104. Pfizer Recent Development
Table 105. Biogen Corporation Information
Table 106. Biogen Description and Major Businesses
Table 107. Biogen Anti-CD20 Monoclonal Antibodies Production (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 108. Biogen Product
Table 109. Biogen Recent Development
Table 110. Genentech Corporation Information
Table 111. Genentech Description and Major Businesses
Table 112. Genentech Anti-CD20 Monoclonal Antibodies Production (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 113. Genentech Product
Table 114. Genentech Recent Development
Table 115. Immunomedics Corporation Information
Table 116. Immunomedics Description and Major Businesses
Table 117. Immunomedics Anti-CD20 Monoclonal Antibodies Production (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 118. Immunomedics Product
Table 119. Immunomedics Recent Development
Table 120. Spectrum Pharmaceuticals Corporation Information
Table 121. Spectrum Pharmaceuticals Description and Major Businesses
Table 122. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Production (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 123. Spectrum Pharmaceuticals Product
Table 124. Spectrum Pharmaceuticals Recent Development
Table 125. Bio-Rad Laboratories Corporation Information
Table 126. Bio-Rad Laboratories Description and Major Businesses
Table 127. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 128. Bio-Rad Laboratories Product
Table 129. Bio-Rad Laboratories Recent Development
Table 130. LFB Biotechnologie Corporation Information
Table 131. LFB Biotechnologie Description and Major Businesses
Table 132. LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2015-2020)
Table 133. LFB Biotechnologie Product
Table 134. LFB Biotechnologie Recent Development
Table 135. Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Regions (2021-2026) (KG)
Table 136. Global Anti-CD20 Monoclonal Antibodies Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Anti-CD20 Monoclonal Antibodies Sales Forecast by Country (2021-2026) (KG)
Table 140. North America: Anti-CD20 Monoclonal Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Anti-CD20 Monoclonal Antibodies Sales Forecast by Country (2021-2026) (KG)
Table 142. Europe: Anti-CD20 Monoclonal Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Anti-CD20 Monoclonal Antibodies Sales Forecast by Region (2021-2026) (KG)
Table 144. Asia Pacific: Anti-CD20 Monoclonal Antibodies Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Anti-CD20 Monoclonal Antibodies Sales Forecast by Country (2021-2026) (KG)
Table 146. Latin America: Anti-CD20 Monoclonal Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Anti-CD20 Monoclonal Antibodies Sales Forecast by Country (2021-2026) (KG)
Table 148. Middle East and Africa: Anti-CD20 Monoclonal Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Anti-CD20 Monoclonal Antibodies Players
Table 153. Anti-CD20 Monoclonal Antibodies Customers List
Table 154. Anti-CD20 Monoclonal Antibodies Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-CD20 Monoclonal Antibodies Product Picture
Figure 2. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2020 & 2026
Figure 3. First Generation Anti-CD20 Monoclonal Antibody Product Picture
Figure 4. Second Generation Anti-CD20 Monoclonal Antibody Product Picture
Figure 5. Third Generation Anti-CD20 Monoclonal Antibody Product Picture
Figure 6. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application in 2020 & 2026
Figure 7. Oncology
Figure 8. Neurology
Figure 9. Immunology
Figure 10. Anti-CD20 Monoclonal Antibodies Report Years Considered
Figure 11. Global Anti-CD20 Monoclonal Antibodies Market Size 2015-2026 (US$ Million)
Figure 12. Global Anti-CD20 Monoclonal Antibodies Sales 2015-2026 (KG)
Figure 13. Global Anti-CD20 Monoclonal Antibodies Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2015-2020)
Figure 15. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region in 2019
Figure 16. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2015-2020)
Figure 17. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region in 2019
Figure 18. Global Anti-CD20 Monoclonal Antibodies Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Anti-CD20 Monoclonal Antibodies Revenue in 2019
Figure 20. Anti-CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Figure 22. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 23. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type (2015-2020)
Figure 24. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type in 2019
Figure 25. Global Anti-CD20 Monoclonal Antibodies Market Share by Price Range (2015-2020)
Figure 26. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Figure 27. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 28. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
Figure 29. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application in 2019
Figure 30. North America Anti-CD20 Monoclonal Antibodies Sales Growth Rate 2015-2020 (KG)
Figure 31. North America Anti-CD20 Monoclonal Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Country in 2019
Figure 33. North America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country in 2019
Figure 34. U.S. Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 35. U.S. Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 37. Canada Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Anti-CD20 Monoclonal Antibodies Market Share by Type in 2019
Figure 39. North America Anti-CD20 Monoclonal Antibodies Market Share by Application in 2019
Figure 40. Europe Anti-CD20 Monoclonal Antibodies Sales Growth Rate 2015-2020 (KG)
Figure 41. Europe Anti-CD20 Monoclonal Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Country in 2019
Figure 43. Europe Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country in 2019
Figure 44. Germany Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 45. Germany Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 47. France Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 49. U.K. Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 51. Italy Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 53. Russia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Anti-CD20 Monoclonal Antibodies Market Share by Type in 2019
Figure 55. Europe Anti-CD20 Monoclonal Antibodies Market Share by Application in 2019
Figure 56. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales Growth Rate 2015-2020 (KG)
Figure 57. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales Market Share by Region in 2019
Figure 59. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region in 2019
Figure 60. China Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 61. China Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 63. Japan Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 65. South Korea Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 67. India Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 69. Australia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 71. Taiwan Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 73. Indonesia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 75. Thailand Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2020) (KG)
Figure 77. Ma
  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs